[Addiction]. / Dépendances.

This year review emphasizes four aspects coming from addiction psychiatry: 1. Initiation and maintenance of cannabis use. 2. Methadone and heart toxicity. 3. Suicidal behaviour in gambling. 4. Treatment of addictive disorders via internet: present and future perspectives.

[Cystic adenomatoid malformation of the lung, bilateral renal agenesis and left heart hypoplasia. An unusual association in Potter's syndrome]. / Malformation adénomatoïde kystique du poumon, agénésie rénale bilatérale et hypoplasie du coeur gauche. Une association inhabituelle dans un syndrome de Potter.

We describe an autopsy case of congenital cystic adenomatoid malformation of the lung (CCAM) associated with bilateral renal agenesis. Prenatal ultrasound examination showed additional left heart hypoplastic syndrome. A therapeutic abortion was induced at 23 weeks of gestation. The association CCAM-bilateral renal agenesis is a rare condition (5 cases previously described) which has to be known because of the mitigation effect of the CCAM on the oligohydramnios determined by bilateral renal agenesis. However, this instance is usually associated with oligohydramnios. The pathogenesis of polyhydramnios in isolated CCAM is discussed in regard with these data.

[Endometrial ablation by fiberoptic hysteroscopy and YAG laser]. / Endométrectomie par hystérofibroscopie et laser Yag.

The authors report the first cases of the use of operating fibre hysteroscopes with YAG laser to carry out endometrial ablation. Fiberoptic hysteroscopes were used and made it possible to carry out the procedure with much greater precision because of their mobility and flexibility. YAG laser rays are passed down an operating channel and can treat the whole of the endometrium in 20 minutes operating time. This treatment was suggested to 44 patients who had menorrhagia and did not respond to treatment with progestogens as an alternative to hysterectomy. There were 81.7% very good results, 11.3% good results and only 7% failures with a followup period of 3 to 20 months. There was no operative or post-operative complication either in the short or the longterm. This technique is a new one and not much used in France, but its advantages have been confirmed by several authors, especially in the United States.

[Prenatal diagnosis of abdomino-pelvic cystic lymphangioma as part of proteus syndrome]. / Diagnostic anténatal d'un lymphangiome kystique abdomino-pelvien s'intégrant dans le cadre d'un syndrome proteus.

Proteus syndrome is difficult to diagnose owing to its low incidence and to the late recognition of its identity, due to polymorphous border diseases and to the polymorphous lesions which characterize. The authors report a prenatal diagnosis of abdominal and pelvic cystic lymphangioma as part of proteus syndrome.

[Fibrinolytic treatment with urokinase and streptokinase for recurrent thrombosis in two valve prostheses for the aortic and mitral valves during pregnancy]. / Traitement fibrinolytique par urokinase et streptokinase d'une thrombose récidivante sur double prothèse valvulaire aortique mitrale au cours de la grossesse.

The authors report a case of a patient who had two episodes of valvular thrombosis successfully treated with fibrinolysis using urokinase and streptokinase. They emphasise how efficient these treatments are in spite of the gravity of the initial picture and also point out the dangers and difficulties that can occur because of the risk of haemorrhage in pregnancy, and particularly during delivery and post-partum. They show once more that the treatment is harmless for the fetus. They conclude that using fibrinolytic treatment should be considered first when there is great danger to the patient, and the advantages and disadvantages of thrombolysis should be weighed up.

[Antithrombin III deficiency and pregnancy. Apropos of a case]. / Déficit en antithrombine III et grossesse. A propos d'un cas.

Congenital deficiency of antithrombin III is a disease inherited as an autosomal dominant which predisposes to thromboembolism. Pregnancy and the postpartum period constitute a major additional risk factor for thromboembolism in deficient women. However, pregnancy may be envisaged without risk since there has been an improvement in knowledge concerning the physiology of the AT III molecule, its exact role in coagulation, the application of accurate laboratory tests which measure the deficiency, and especially the programming of pregnancy under cover of preventive treatment consisting of the perfusion of AT III concentrate in association with heparin. The treatment is restricting and costly but is, nevertheless, the only one to recreate conditions that are similar to physiological conditions, and its effect is therefore more certain.